SILO PHARMA, INC. Debt Instrument, Interest Rate, Increase (Decrease)
SILO PHARMA, INC. (SILO) reported Debt Instrument, Interest Rate, Increase (Decrease) of 18.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateIncreaseDecrease · last filed 2023-03-24
- SILO PHARMA, INC. debt instrument, interest rate, increase (decrease) for the quarter ending 2022-03-31 was 18.00%.
- SILO PHARMA, INC. debt instrument, interest rate, increase (decrease) for fiscal 2022 was 18.00%.
| Period end | Debt Instrument, Interest Rate, Increase (Decrease) 3 month | Debt Instrument, Interest Rate, Increase (Decrease) 6 month | Debt Instrument, Interest Rate, Increase (Decrease) 9 month | Debt Instrument, Interest Rate, Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2022-12-31 | 18.00% 10-K · filed 2023-03-24 | |||
| 2022-09-30 | 18.00% 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 18.00% 10-Q · filed 2022-08-01 | |||
| 2022-03-31 | 18.00% 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |